Tag: SPEX

Blue Horseshoe Stocks: PBR, ACHN, TMSH & More

Petroleo Brasiliero S.A. (Petrobras) PBR

We’ll kick things off this morning with PBR once again, as the stock had another banner day and behaved very much like we suggested it might. Yesterday we mentioned that the PBR chart was looking ripe for further northward movement and that’s just what we got.

The stock itself broke back over $15, which led to some prime opportunities in each and every set of options contracts that we outlined in our morning report. We said we’d be looking at Weekly Calls from $14-$15 for quick-flip intraday opportunities, and they all offered up some serious gains.

The $14 Calls traded from .74 to as high as 1.09, a chance for traders to score up to 47% in profits. The $14.50’s made a nice move up from .34 to .75, good for a nice double-bagger and more at +120% The $15’s fared extremely well also, running a whopping 290% from .11 up to .43.

Even our contracts of longer-term interest, the 07/19 $15 Calls (which we caught at a low of .25) made a solid intraday move from .54-.84, a highly respectable 55% increase.

All in all, for options traders, PBR was a paradise on Monday, and we’ll be continuously monitoring the situation as the week progresses. Major areas of resistance appear on the chart at 15.50 and 15.85, so failure to pierce through that channel would certainly be a signal to us to take profits off of the table. In order to keep our interest levels high, PBR will need to maintain support above the 15-dollar mark.

Achillion Pharmaceuticals, Inc. ACHN

Appearing in yesterday’s extended watchlist, ACHN was another play with potential to start off a new week. After a significant morning gap-up, the stock would touch a low of 3.72 before running as high as 4.82, an intraday move of 30%

This morning the company came with a well-timed release concerning its Hep-C drug, and the stock continues to blow its top. The high this morning in premarket trading is 6.47, making ACHN one that we’ll definitely be interested to follow. Per this morning’s PR, there’s a timeline for the testing of this drug leading all the way up to the end of the year, so we’ll stick ACHN on our longer-term radar as well.

NEW HAVEN, Jun 10, 2014 (GLOBE NEWSWIRE via COMTEX) — Initial cohort of HCV-infected patients begin dosing with ACH-3422 for seven days. Clinical trials may continue evaluating 200 mg of sovaprevir for HCV-infected patients. Timelines for reporting proof-of-concept results with ACH-3422, a proprietary uridine-analog nucleotide polymerase inhibitor, during the fall of 2014 and initiating all-oral combination studies by the end of 2014 remain on track >>> FULL PR

TransGlobal Assets, Inc. TMSH

We’ve been following TMSH since last week, and have not been disappointed. The stock has played out a textbook dip-and-rip scenario for the last three sessions straight, offering up many opportunities to make gains.

Yesterday, it came down as low as .0079 before ripping its way up to .0128, a healthy intraday increase of 62% Provided it continues to trade in this manner, we’ll be looking to take advantage of any similar swings to the ones we’ve seen already. We want to see it make higher lows, and break through the channel of resistance between the previous two sessions’ swing highs (.0128-.0139).

Side Note:

Even with so much else to talk about today, we can’t forget about another cash cow in Apple. AAPL Calls have been providing us with some excellent opportunities in recent weeks as well, and we’re still highly attuned to that situation as well.

Extended Watchlist:
DNAX, SPEX, AVNR, SGMS, ATEA, TPLM, KNDI

Blue Horseshoe Stocks: ACGX Update

Alliance Creative Group, Inc. ACGX

We thought today would be a good time to revisit ACGX given the current positioning of the chart. For some of our newer readers; this was a play that has afforded us the chance at some stellar gains over the past couple of months.

Following a huge run to more than a penny back in April, we monitored ACGX for a bottom, which it found at .0035 (May 9th). Since that time, it has made a couple of significant swings, where it has run into some resistance at the .006-.0064 area. We are currently observing another strong move off of its most recent swing-low, with the stock having made higher lows for the past five consecutive sessions.

As you can see on the included chart, ACGX is on the fringe of cracking through its 50DMA, the RSI is about to flip up to the strong side, and the MACD appears to be setting up for a bullish cross. With these factors in alignment, we’re going to want to pay closer attention to ACGX over the course of the week.

Remember, per a recent PR, at the end of the month Alliance will be attending the 1st Annual Weedstock Conference in Denver (June 29-July 1), so we’ll be interested to receive an update on that come July.

More Info:
AllianceCreativeGroup.com


Provectus Biopharmaceuticals, Inc. PVCT

We spotted PVCT on a routine scan this morning, and wanted to include it given the current situation. The stock recently became the target of an upcoming class action lawsuit, and was actually halted on May 23rd. this led to a major selloff when trading resumed, triggering a gap-down.

It appears as if the firm handling suit has another couple of months to pull together plaintiffs for the case, so we’ll be long gone by the time that comes around. We are interested in PVCT purely for the potential for quick-strike opportunities as it corrects itself off of its recent lows in the .30-.70 range.

The re-filling of even a fraction of the gap on the chart could mean rapid profits for us, so we’ll be keeping an eye on this stock over the next few sessions.

Extended Watchlist:
IAG, DARA, SPEX, FREE, RNA, PBR

Blue Horseshoe Stocks: Update on AAPL & Extended Watchlist

Apple, Inc. AAPL – Options

On Friday, our morning report contained a blurb in which we stated we’d be “hot on the trail of potential gains in the Apple options chain”, and we certainly hope folks got in on some of the action that ensued. We have been following AAPL quite heavily since our report on Wed. the 14th, wherein we commented on the Apple-Beats buyout rumor.

AAPL stock tore out of the gate, bulling its way up all day to more than $614 just prior to the close. As a result, the options contracts we were following in the $605-610 range steadily ramped up in price over the course of the session.

As you can see on the graphic below, some truly notable gains were possible for anyone trading these contracts. The daily ranges on these things were quite impressive:

$605 Calls – Day’s Range: 2.15-9.76 – Max Gain: 354%

$607 Calls – Day’s Range: .83-7.13 – Max Gain: 759%

$610 Calls – Day’s Range: .25-4.70 – Max Gain: 1780%

It really wouldn’t have mattered which Calls you were into on Friday- traders literally could have thrown a dart at a board filled with contracts and come up with a winner!

AAPL continued to press upward this morning, as the stock has traded as high as the 618.90’s in pre-market activities. Now that it has broken well above the previous resistance point of $607.33, that’s the level we’d like to see hold as support in the event of any pullbacks.

Other stocks that had significant gains in the options calls from last week that we want to continue to monitor this week include: DDD, TSLA, GOGO, DDD & FEYE


Side Note:

Triton Distribution Systems, Inc. TTDZ now trading as:
Green Cures & Botanical Distribution Inc. GRCU

TTDZ, a stock that has given us many chances to profit in 2014, finally underwent the name and symbol change that we had been anticipating, becoming GRCU.

If you recall, this play was one of the largest runners we encountered during the “green rush” earlier this year. We caught it at a low of .0012 on January 30th, and subsequently rode it to a high of .049 in early April. For anyone without a calculator handy, that equates to a staggering move of 3983% in just over two months time! It’s hard not to call that one of our biggest successes of the year so far.

The company has also gone live with a new website that you can find @ http://gcbdinc.com/

We’re going to begin monitoring this, and other marijuana related plays more heavily in coming weeks. As many of you will remember, we’re anxiously awaiting the start of legal sales in Washington State, presently slated for mid-July. It could very well provide the cannabis sector with another swell of interest and buying, much like the beginning of sales in Colorado did back in January, which of course sparked one of the most monumental sector surges the penny markets have ever seen.

Extended Watchlist:
BCRX, ARO, VRNG, INO, SPEX, ADXS